Breaking News
13 hours ago
Mrudula Kulkarni
Mrudula Kulkarni
MMV and Quotient Sciences begin the first clinical trial of an injectable preventive for malaria, MMV371.
Simantini Singh Deo
CluePoints appoints Richard Young as Chief Strategy Officer to drive growth in RBQM and AI-driven SaaS.
Simantini Singh Deo
AbbVie acquires Aliada for $1.4B, gaining CNS-focused BBB technology and Alzheimer's candidate ALIA-1758.
Simantini Singh Deo
Evoke Pharma and EVERSANA present GIMOTI data showing reduced ER visits for DGP patients on GLP-1.
Mrudula Kulkarni